What's up, everybody?

Welcome back to Iron Culture presented by the mass research review.

I am Eric Trexler, joined as always by the Dr. Eric Helms.

Helms, how are we doing tonight?

Oh, I'm doing fabulous this Wednesday morning.

And that's because I just got off of now Dr. Josh Pellon's defense.

I had the privilege of serving on his committee in my external role with FAU,

Florida Atlantic University, with our mutual colleague, Dr. Mike Zerdos.

And, no, it's been really cool to watch Josh's progression.

You know, I was actually on his master's committee, and now he is just completed his defense.

And he had a really cool topic where he was investigating the concept of resensitization, something that has been promoted a lot in kind of the modern hypertrophy training space, where the idea is, hey,

if we use strategic delodes, can we potentially grow faster following these periods of doing less

total stimulus from training? And the basic idea when you

really think about it is can we have our cake and eat it too? Because a lot of the concepts of

resensitization or growing faster following a deloading period are actually based upon studies

and models where the participants lost muscle.

So they experienced atrophy. And then the question is, well, hold on, are we actually seeing a net

advantage? Or are we just seeing that atrophy allows you to grow faster afterwards? So his question

was all related to creating a study design.

So if we don't have atrophy, we maintain muscle, we kind of go to that minimum effective dose of

training. Can we then grow faster after bringing in the old dose? And I won't spoil the plot.

He is going to be probably talking about that on heaps of podcasts. There is an open attendance for this

...